Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
NCT ID: NCT04375579
Last Updated: 2024-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
205 participants
OBSERVATIONAL
2020-07-03
2024-10-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT
NCT06946654
Allogeneic Hematopoietic Stem Cell Transplantation Evaluation in High Risk Myelodysplasia: an Observational Non-interventional Study
NCT01095874
Prehabilitation to Improve Frailty, Function, and Quality of Life in Candidates for Hematopoietic Stem Cell Transplantation
NCT07255521
Prospective Observational Clinical Study on Changes in Cognitive Levels in Elderly Patients Before and After Hematopoietic Stem Cell Transplantation
NCT06484049
Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning
NCT00466674
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Comprehensive geriatric assessment (CGA)
Questionnaires on nutritional status, autonomy and quality of life
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient receiving a hematopoietic stem cell allograft for myeloid hemopathy (myeloid acute leukemia, myelodysplastic syndrome, Myeloproliferative neoplasm) or for an Acute lymphoblastic leukemia
* No opposition to participate
Exclusion Criteria
* Vulnerable patients protected by curatorship or administrative supervision
* Patients not covered by a social security scheme
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Amiens
Amiens, , France
CHU Angers
Angers, , France
CHU Besancon
Besançon, , France
CHU Bordeaux
Bordeaux, , France
CHU Caen
Caen, , France
CHU Clermont-Ferrand
Clermont-Ferrand, , France
CHU Grenoble
Grenoble, , France
CHRU Lille
Lille, , France
CHU Limoges
Limoges, , France
CHU Lyon
Lyon, , France
CHU Montpellier
Montpellier, , France
CHRU Nancy
Nancy, , France
CHU Nantes
Nantes, , France
CHU Nice
Nice, , France
Hopital de la Pitié Salpetrière
Paris, , France
Hopital Necker
Paris, , France
Hopital Saint Louis
Paris, , France
CHU Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APHP200084
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.